Cereblon ligands and bifunctional compounds comprising the same

A technology of bifunctional compounds and compounds, applied in the fields of active ingredients of heterocyclic compounds, drug combinations, organic chemistry, etc.

Pending Publication Date: 2021-01-22
ARVINAS OPERATIONS INC
View PDF28 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, non-specific effects and inability to fully target and regulate certain classes of proteins such as transcription factors remain obstacles to the development of effective anticancer agents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cereblon ligands and bifunctional compounds comprising the same
  • Cereblon ligands and bifunctional compounds comprising the same
  • Cereblon ligands and bifunctional compounds comprising the same

Examples

Experimental program
Comparison scheme
Effect test

example

[1890] A. Protein Degradation Bioassay:

[1891] The following bioassays use representative compounds disclosed herein to assess the levels of protein degradation observed in various cell types.

[1892] In each bioassay, cells are treated with varying amounts of a compound encompassed by the present disclosure. Degradation of the following proteins can be assessed: estrogen receptor alpha (ERα), bromodomain-containing protein 4 (BRD4), androgen receptor (AR) and BRaf proteins.

[1893] 1. ERE Luciferase Assay for Compounds in Table 5

[1894] T47D-KBluc cells ( #CRL_2865, T47D human breast cancer cells stably transfected by estrogen response element / promoter / luciferase reporter gene) were seeded into 96 wells in RPMI growth medium supplemented with 10% fetal bovine serum (FBS) white opaque plates and allowed to adhere overnight in a humidified incubator at 37°C. The next day, cells were treated with PROTACs in a 12-point concentration curve (highest final concentration...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The description relates to cereblon E3 ligase binding compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present disclosure. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.

Description

[0001] Cross References to Related Applications [0002] This disclosure is an international application claiming priority to U.S. nonprovisional application No. 15 / 953108, filed April 13, 2018, which is claiming U.S. provisional application No. 1, filed April 14, 2014. 61 / 979,351 is a continuation-in-part of U.S. nonprovisional application filed April 14, 2015 and is claiming U.S. provisional application 61 / 979,351 filed April 14, 2014 and filed on June 14, 2015 Continuation-in-Part of U.S. Nonprovisional Application No. 14 / 792,414, filed July 6, 2015, which is the priority of U.S. Provisional Application No. 62 / 171,090, filed July 4, 2015, all of which are hereby incorporated by reference in their entirety middle. [0003] incorporated by reference [0004] U.S. Patent Application Serial No. 15 / 230,354, filed August 5, 2016, published as U.S. Patent Application Publication No. 2017 / 0065719; and U.S. Patent Application Serial No. 15 / 801,243, filed November 1, 2017; and U....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/14C07D471/04C07D487/04C07D495/14A61P35/00A61K31/438A61K31/496A61K31/53A61K31/519
CPCC07D401/14C07D471/04C07D487/04C07D495/14A61P35/00C07D401/04A61K31/4439A61K31/444A61K31/519A61K31/517A61K31/55A61K31/5517A61K31/437A61K31/4985A61K45/06C07D498/14
Inventor A·P·克鲁C·M·克鲁斯董汉清K·R·霍恩伯格王警钱义民K·齐默尔曼M·伯林L·B·斯奈德
Owner ARVINAS OPERATIONS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products